Search research articles
Contact Us
Filters
Showing results (161-170 of 248) with videos related to
Page
of 25
Sort By:
The Lancet. Oncology
|
September 1, 2005
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial
Bryan H Burmeister, B Mark Smithers, Val Gebski, et al.
ANZ Journal of Surgery
|
March 29, 2007
A pilot study of preoperative and postoperative chemotherapy in patients with operable gastric cancer: Australasian Gastrointestinal Trials Group Study 9601
Michael Findlay, David Storey, Val Gebski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2015
Impact of Specific Epidermal Growth Factor Receptor (EGFR) Mutations and Clinical Characteristics on Outcomes After Treatment With EGFR Tyrosine Kinase Inhibitors Versus Chemotherapy in EGFR-Mutant Lung Cancer: A Meta-Analysis
Chee Khoon Lee, Yi-Long Wu, Pei Ni Ding, et al.
Frontiers in Psychology
|
October 2, 2023
Self-reported traumatic brain injury in a sample of impulsive violent offenders: neuropsychiatric correlates and possible "dose effects"
Vasudeva Murthy Challakere Ramaswamy, Tony Butler, Bianca Ton, et al.
British Journal of Cancer
|
December 14, 2023
Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancer
Danka Sinikovic Zebic, Angelina Tjokrowidjaja, Katherine Elizabeth Francis, et al.
British Journal of Cancer
|
January 25, 2017
Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist)
Kristina Lindemann, Emma Gibbs, Elisabeth Åvall-Lundqvist, et al.
Diabetes, Obesity & Metabolism
|
April 4, 2020
Uric acid predicts long-term cardiovascular risk in type 2 diabetes but does not mediate the benefits of fenofibrate: The FIELD study
Jacob Y Cao, Boris Waldman, Rachel O'Connell, et al.
Gynecologic Oncology
|
October 5, 2014
Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: analysis of the CALYPSO trial
Chee Khoon Lee, Sarah Lord, Tami Grunewald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 29, 2024
LACC Trial: Final Analysis on Overall Survival Comparing Open Versus Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer
Pedro T Ramirez, Kristy P Robledo, Michael Frumovitz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 7, 2019
Development and validation of a prognostic nomogram for overall survival in patients with platinum-resistant ovarian cancer treated with chemotherapy
Chee Khoon Lee, Rebecca Asher, Michael Friedlander, et al.
Page
of 25
Search research articles
Search
Showing results (161-170 of 248) with videos related to
Sort By:
Page
of 25
The Lancet. Oncology
|
September 1, 2005
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial
Bryan H Burmeister, B Mark Smithers, Val Gebski, et al.
ANZ Journal of Surgery
|
March 29, 2007
A pilot study of preoperative and postoperative chemotherapy in patients with operable gastric cancer: Australasian Gastrointestinal Trials Group Study 9601
Michael Findlay, David Storey, Val Gebski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2015
Impact of Specific Epidermal Growth Factor Receptor (EGFR) Mutations and Clinical Characteristics on Outcomes After Treatment With EGFR Tyrosine Kinase Inhibitors Versus Chemotherapy in EGFR-Mutant Lung Cancer: A Meta-Analysis
Chee Khoon Lee, Yi-Long Wu, Pei Ni Ding, et al.
Frontiers in Psychology
|
October 2, 2023
Self-reported traumatic brain injury in a sample of impulsive violent offenders: neuropsychiatric correlates and possible "dose effects"
Vasudeva Murthy Challakere Ramaswamy, Tony Butler, Bianca Ton, et al.
British Journal of Cancer
|
December 14, 2023
Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancer
Danka Sinikovic Zebic, Angelina Tjokrowidjaja, Katherine Elizabeth Francis, et al.
British Journal of Cancer
|
January 25, 2017
Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist)
Kristina Lindemann, Emma Gibbs, Elisabeth Åvall-Lundqvist, et al.
Diabetes, Obesity & Metabolism
|
April 4, 2020
Uric acid predicts long-term cardiovascular risk in type 2 diabetes but does not mediate the benefits of fenofibrate: The FIELD study
Jacob Y Cao, Boris Waldman, Rachel O'Connell, et al.
Gynecologic Oncology
|
October 5, 2014
Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: analysis of the CALYPSO trial
Chee Khoon Lee, Sarah Lord, Tami Grunewald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 29, 2024
LACC Trial: Final Analysis on Overall Survival Comparing Open Versus Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer
Pedro T Ramirez, Kristy P Robledo, Michael Frumovitz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 7, 2019
Development and validation of a prognostic nomogram for overall survival in patients with platinum-resistant ovarian cancer treated with chemotherapy
Chee Khoon Lee, Rebecca Asher, Michael Friedlander, et al.
Page
of 25